Inhibition of mammalian target of rapamycin as a therapeutic strategy in the management of bladder cancer

被引：0
|
作者：
Mansure, Jose [1 ]
Nassim, Roland [1 ]
Rocha, Joice [1 ]
Scarlata, Eleonora [1 ]
Chevalier, Simone [1 ]
Kassouf, Wassim [1 ]
机构：
[1] McGill, Montreal, PQ, Canada
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2879
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Inhibition of mammalian target of rapamycin: Two goals with one shot?
    Soll, Christopher
    Clavien, Pierre-Alain
    JOURNAL OF HEPATOLOGY, 2011, 54 (01) : 182 - 183
  • [42] Mechanisms of mammalian target of rapamycin inhibition in sarcoma: present and future
    MacKenzie, Amy R.
    von Mehren, Margaret
    EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (08) : 1145 - 1154
  • [43] Regression of left ventricular hypertrophy by inhibition of mammalian target of rapamycin
    Gao, XM
    Wong, G
    Wang, BH
    Moore, XL
    Su, YD
    Xu, Q
    Du, XJ
    CIRCULATION RESEARCH, 2005, 97 (02) : E31 - E31
  • [44] Changes in tumor metabolism as readout for mammalian target of rapamycin kinase inhibition by rapamycin in glioblastoma
    Wei, Liu Hua
    Su, Helen
    Hildebrandt, Isabel J.
    Phelps, Michael E.
    Czernin, Johannes
    Weber, Wolfgang A.
    CLINICAL CANCER RESEARCH, 2008, 14 (11) : 3416 - 3426
  • [45] LUTEOLIN SUPPRESSES SQUAMOUS DIFFERENTIATION OF BLADDER CANCER AND CANCER GROWTH VIA REGULATION OF MAMMALIAN TARGET OF RAPAMYCIN PATHWAY
    Iida, Keitaro
    Naiki-Ito, Aya
    Nagai, Takashi
    Nozaki, Satoshi
    Etani, Toshiki
    Naiki, Taku
    Kawai, Noriyasu
    Takahashi, Satoru
    Yasui, Takahiro
    JOURNAL OF UROLOGY, 2021, 206 : E656 - E657
  • [46] LUTEOLIN SUPPRESSES SQUAMOUS DIFFERENTIATION OF BLADDER CANCER AND CANCER GROWTH VIA REGULATION OF MAMMALIAN TARGET OF RAPAMYCIN PATHWAY
    Iida, Keitaro
    Naiki, Taku
    Naiki-Ito, Aya
    Nagai, Takashi
    Nozaki, Satoshi
    Etani, Toshiki
    Ando, Ryosuke
    Kawai, Noriyasu
    Yasui, Takahiro
    JOURNAL OF UROLOGY, 2020, 203 : E5 - E5
  • [47] Inhibition of the mammalian target of rapamycin (mTOR) by rapamycin increases chemosensitivity of CaSki cells to paclitaxel
    Faried, L. S.
    Faried, A.
    Kanuma, T.
    Nakazato, T.
    Tamura, T.
    Kuwano, H.
    Minegishi, T.
    EUROPEAN JOURNAL OF CANCER, 2006, 42 (07) : 934 - 947
  • [48] Discovery of Novel Dual Histone Deacetylase and Mammalian Target of Rapamycin Target Inhibitors as a Promising Strategy for Cancer Therapy
    Chen, Yong
    Yuan, Xue
    Zhang, Wanhua
    Tang, Minghai
    Zheng, Li
    Wang, Fang
    Yan, Wei
    Yang, Shengyong
    Wei, Yuquan
    He, Jun
    Chen, Lijuan
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (03) : 1577 - 1592
  • [49] Controversies in breast cancer: The mammalian target of rapamycin as a target for breast cancer therapy
    Di Cosimo S.
    Breast Cancer Research, 11 (Suppl 3)
  • [50] The Role of Targeting Mammalian Target of Rapamycin in Lung Cancer
    Pal, Sumanta Kumar
    Figlin, Robert A.
    Reckamp, Karen L.
    CLINICAL LUNG CANCER, 2008, 9 (06) : 340 - 345
12345